Last reviewed · How we verify
Efficacy and Safety of OROS® Oxybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence
The purpose of this study is to compare the side-effect profile and efficacy of sustained release, OROS® and TTS, dosage forms of oxybutynin with immediate release (IR) oral oxybutynin and with placebo.
Details
| Lead sponsor | Alza Corporation, DE, USA |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 176 |
| Start date | 1995-12 |
| Completion | 1996-12 |
Conditions
- Urinary Incontinence
Interventions
- Oxybutynin
Primary outcomes
- The primary efficacy parameter is the mean change in urge incontinence episodes per week from baseline to last week after up to 6 weeks double-blind treatment.